ICX-TRC - Frequently Asked Questions
Intercytex is asked many questions about ICX-TRC, so in response, this new web-page has been created to provide some answers.
Please note: ICX-TRC is at an early stage of its development and there are still many unknowns which will become clearer as the clinical programme develops and the regulatory environment matures. The answers given below are provided by Intercytex in good faith based on current knowledge, but they are subject to change due to clinical trial results, scientific research or other factors which influence the development of new healthcare products. Therefore, anyone reading the information below is asked to do so in the same spirit and should not alter any current or future medication or hair treatment plan as a result.
Our web-site is frequently updated so please see the relevant pages for the latest information on ICX-TRC.
When this page is amended, an alert will be sent to everyone who has registered via the alert service, which can be found on the upper navigation bar on the Home page of this website.
1. How can I receive ICX-TRC?
ICX-TRC is currently in Phase II clinical trials in the UK, so it is not yet widely available.
2. When will ICX-TRC be on the market?
ICX-TRC is classified as a medicine by the regulatory authorities and hence has to undergo a series of clinical trials before it can be offered on the market. We currently estimate that the earliest that ICX-TRC would be available on the market is 2010 although we don't know in which country it will be launched first.
3. How can I stay in touch with ICX-TRC’s progress?
Please watch our website for news and announcements about ICX-TRC and sign up via the news alert so you can stay up-to-date with our progress.
4. When will the Phase II trial be completed?
It is a rolling trial which will optimise the formulation and delivery as well as studying safety and efficacy. We expect some data will become available during 2007. We anticipate the current trial will complete during 2008.
5. Will there be a Phase II or III trial in the US?
At the moment the Phase II trial will be conducted in the UK only. Phase III trials may be conducted in both the US and the UK but plans to do so have not been finalised.
6. May I take part in the Phase II clinical trial?
The trials are being conducted at the Farjo Medical Centre in Manchester so all volunteers need to come from that area of the UK, partly for safety re
Intercytex is asked many questions about ICX-TRC, so in response, this new web-page has been created to provide some answers.
Please note: ICX-TRC is at an early stage of its development and there are still many unknowns which will become clearer as the clinical programme develops and the regulatory environment matures. The answers given below are provided by Intercytex in good faith based on current knowledge, but they are subject to change due to clinical trial results, scientific research or other factors which influence the development of new healthcare products. Therefore, anyone reading the information below is asked to do so in the same spirit and should not alter any current or future medication or hair treatment plan as a result.
Our web-site is frequently updated so please see the relevant pages for the latest information on ICX-TRC.
When this page is amended, an alert will be sent to everyone who has registered via the alert service, which can be found on the upper navigation bar on the Home page of this website.
1. How can I receive ICX-TRC?
ICX-TRC is currently in Phase II clinical trials in the UK, so it is not yet widely available.
2. When will ICX-TRC be on the market?
ICX-TRC is classified as a medicine by the regulatory authorities and hence has to undergo a series of clinical trials before it can be offered on the market. We currently estimate that the earliest that ICX-TRC would be available on the market is 2010 although we don't know in which country it will be launched first.
3. How can I stay in touch with ICX-TRC’s progress?
Please watch our website for news and announcements about ICX-TRC and sign up via the news alert so you can stay up-to-date with our progress.
4. When will the Phase II trial be completed?
It is a rolling trial which will optimise the formulation and delivery as well as studying safety and efficacy. We expect some data will become available during 2007. We anticipate the current trial will complete during 2008.
5. Will there be a Phase II or III trial in the US?
At the moment the Phase II trial will be conducted in the UK only. Phase III trials may be conducted in both the US and the UK but plans to do so have not been finalised.
6. May I take part in the Phase II clinical trial?
The trials are being conducted at the Farjo Medical Centre in Manchester so all volunteers need to come from that area of the UK, partly for safety re